Core Viewpoint - Suzhou Tianmai (301626.SZ) reported a strong performance in Q3, with significant year-on-year growth in both revenue and net profit [1] Financial Performance - The company's operating revenue for the first three quarters reached 818 million yuan, representing a year-on-year increase of 18.42% [1] - The net profit attributable to shareholders of the listed company was 140 million yuan, showing a year-on-year growth of 1.54% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 137 million yuan, reflecting a year-on-year increase of 2.24% [1]

二、董事会审议情况 一、董事会会议召开情况 经与会董事认真审议，形成了如下决议： 苏州天脉导热科技股份有限公司（以下简称"公司"）第三届董事会第十三 次会议于 2025 年 10 月 23 日在公司会议室以现场会议和通讯会议相结合的方式 召开。会议通知于 2025 年 10 月 17 日以电子邮件方式发出。本次会议应出席董 事 7 人，实际出席董事 7 人。会议由董事长谢毅先生主持，公司其他高级管理人 员列席会议（部分董事及部分高级管理人员通过通讯方式参加会议）。本次会议 的召集、召开程序符合相关法律法规和《苏州天脉导热科技股份有限公司章程》 （以下简称"《公司章程》"）的规定。 证券代码：301626 证券简称：苏州天脉 公告编号：2025-042 苏州天脉导热科技股份有限公司 第三届董事会第十三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 因公司内部工作调整，史国昌先生申请辞去公司第三届董事会董事、战略委员会 委员职务。同日，经公司职工代表大会选举，史国昌先生担任公司第三届董事会 职工代表董事。具体内容详见公司于 2025 年 10 月 ...

Financial Performance - The company's operating revenue for Q3 2025 reached ¥310,385,491.16, representing a 32.51% increase year-over-year[6] - Net profit attributable to shareholders for Q3 2025 was ¥48,111,335.82, up 9.63% compared to the same period last year[6] - The net profit after deducting non-recurring gains and losses was ¥46,718,562.81, reflecting a 9.67% increase year-over-year[6] - Total operating revenue for the third quarter of 2025 reached CNY 818,435,475.37, an increase of 18.4% compared to CNY 691,112,868.28 in the same period last year[25] - Net profit for Q3 2025 was CNY 142,565,381.87, up 1.5% from CNY 140,400,458.46 in Q3 2024[29] - The total profit for Q3 2025 was CNY 157,827,238.65, a decrease of 0.7% from CNY 158,889,919.85 in Q3 2024[28] Assets and Liabilities - The total assets at the end of Q3 2025 amounted to ¥1,797,383,589.01, a 5.92% increase from the end of the previous year[6] - Current assets totaled CNY 1,091,068,952.47, a slight decrease from CNY 1,124,128,875.21 at the beginning of the period[23] - Total liabilities increased to CNY 222,316,005.55 from CNY 199,332,049.41, marking an increase of 11.0%[25] - Non-current assets totaled CNY 706,314,636.54, up from CNY 572,723,803.22, reflecting an increase of 23.3%[24] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,811[16] - The largest shareholder, Xie Yi, holds 40.83% of shares, totaling 47,236,077 shares[16] - The company reported a total of 47,236,077 restricted shares held by shareholder Xie Yi, which are set to be released on February 24, 2027[19] - Shareholder Shen Fenghua holds 13,725,000 restricted shares, also scheduled for release on February 24, 2027[19] - The company has 5,344,500 restricted shares held by Guokai Manufacturing Transformation and Upgrade Fund, with a release date of February 24, 2025[19] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥129,114,012.09, a decrease of 27.45% compared to the previous year[6] - Cash flow from operating activities for Q3 2025 was CNY 129,114,012.09, down 27.4% from CNY 177,953,363.16 in Q3 2024[32] - Cash inflow from investing activities surged by 1484.71% to CNY 1,751,225,824.77, driven by an increase in cash management recoveries[14] - The company reported a net cash outflow from financing activities of CNY 69,630,205.13, compared to a net outflow of CNY 64,093,914.61 in Q3 2024[32] Expenses - Research and development expenses for the first nine months of 2025 totaled ¥69,703,810.14, a 36.20% increase year-over-year due to higher personnel costs[13] - Total operating costs for Q3 2025 were CNY 664,683,284.01, an increase of 23.3% from CNY 539,057,883.57 in Q3 2024[28] - Other income fell by 49.71% to CNY 5,320,862.84 primarily due to a reduction in government subsidies related to income[14] Earnings Per Share - The basic earnings per share for Q3 2025 was ¥0.42, down 17.65% from the same period last year[6] - Basic and diluted earnings per share for Q3 2025 were CNY 1.23, down from CNY 1.62 in Q3 2024[29] Changes in Equity - The equity attributable to shareholders increased to ¥1,575,067,583.46, marking a 5.18% rise compared to the previous year[6] - The company's retained earnings increased to CNY 641,868,567.02 from CNY 564,083,985.15, a growth of 13.8%[25]

Core Viewpoint - Suzhou Tianmai Thermal Technology Co., Ltd. is set to release 26,590,998 shares for trading on October 24, 2025, which represents 22.99% of the company's total share capital, following the expiration of the lock-up period for certain pre-IPO and strategic placement shares [2][5][11]. Group 1: Share Issuance and Lock-up Details - The total number of shares to be released is 26,590,998, accounting for 22.99% of the total share capital [5][11]. - The number of shareholders applying for the release of lock-up shares is 19 [12]. - The lock-up period for these shares is 12 months from the date of the company's IPO on October 24, 2024 [5][12]. Group 2: Share Capital Structure - Prior to the IPO, the total share capital was 86,760,000 shares, which increased to 115,680,000 shares post-IPO [4]. - After the IPO, 21,992,305 shares (19.01%) are unrestricted, while 93,687,695 shares (80.99%) are subject to lock-up [4]. - As of the announcement date, the total share capital remains at 115,680,000 shares, with 89,652,000 shares (77.50%) under lock-up and 26,028,000 shares (22.50%) unrestricted [4]. Group 3: Shareholder Commitments - Shareholders have made commitments not to transfer or manage their pre-IPO shares for 36 months from the issuance date and for 12 months from the IPO date [8][9]. - The commitments include adherence to regulations set by the China Securities Regulatory Commission and the Shenzhen Stock Exchange regarding share transfers and disclosures [9][10]. Group 4: Regulatory Compliance - The sponsor has confirmed that the release of lock-up shares complies with relevant regulations and that shareholders have adhered to their commitments [15]. - The company has ensured that there are no violations regarding the use of funds by shareholders or illegal guarantees [10].

Core Points - Suzhou Tianmai announced the release of lock-up shares for trading, which includes shares issued before the initial public offering (IPO) and strategic placement shares [1] - A total of 19 shareholders are involved in this lock-up release, with a total of 26,590,998 shares being released, representing 22.99% of the company's total share capital [1] - Among the released shares, 23,698,998 shares (20.49% of total share capital) are from pre-IPO shareholders, while 2,892,000 shares (2.50% of total share capital) are from strategic placement shareholders [1] - The lock-up period for these shares is set for 12 months from the date of the company's IPO, with the shares expected to be tradable starting October 24, 2025 [1]

国投证券股份有限公司 关于苏州天脉导热科技股份有限公司 部分首次公开发行前已发行股份及首次公开发行战略 配售股份解除限售并上市流通的核查意见 国投证券股份有限公司（以下简称"国投证券"或"保荐人"）作为苏州 天脉导热科技股份有限公司（以下简称"苏州天脉"或"公司"）首次公开发 行股票并在创业板上市的保荐人，根据《证券发行上市保荐业务管理办法》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第2 号——创业板上市公司规范运作》等有关法律、法规和规范性文件的要求，对苏 州天脉部分首次公开发行前已发行股份及首次公开发行战略配售股份解除限售并 上市流通事项进行了核查，具体情况如下： 一、首次公开发行股份概况 经中国证券监督管理委员会《关于同意苏州天脉导热科技股份有限公司首次 公开发行股票注册的批复》（证监许可[2024]479号）同意注册，公司首次公开 发行人民币普通股（A股）2,892.00万股，并于2024年10月24日在深圳证券交易 所创业板上市交易。 首次公开发行前总股本86,760,000股，首次公开发行股票完成后公司总股本 为115,680,000股，其中无流通限制或限售安排股票 ...

证券代码：301626 证券简称：苏州天脉 公告编号：2025-041 苏州天脉导热科技股份有限公司 关于部分首次公开发行前已发行股份及首次公开发行战略 配售股份解除限售并上市流通的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、苏州天脉导热科技股份有限公司（以下简称"苏州天脉"或"公司"） 本次解除限售并上市流通的股份为部分首次公开发行前已发行股份和首次公开 发行战略配售股份。 2、本次申请解除限售股东户数为 19 户，限售股份数量合计为 26,590,998 股，占公司总股本的比例为 22.99%，其中首次公开发行前已发行股份的股东 17 户，本次申请解除限售股份 23,698,998 股，占公司总股本比例为 20.49%；首次 公开发行战略配售股份的股东 2 户，本次申请解除限售股份 2,892,000 股，占公 司总股本比例为 2.50%，限售期均为自公司首次公开发行股票上市之日起 12 个 月。 3、本次拟解除限售的股份上市流通日期为 2025 年 10 月 24 日（星期五）。 一、首次公开发行股份概况 经中国证券监督管 ...

Core Insights - Suzhou Tianmai's stock increased by 5.69%, reaching 127.89 CNY per share, with a total market capitalization of 14.794 billion CNY [1] Company Overview - Suzhou Tianmai Thermal Technology Co., Ltd. was established on July 25, 2007, and is located at 68 Huikai Road, Luzhi Town, Wuzhong District, Suzhou [1] - The company specializes in the research, production, and sales of thermal management materials and components, with 98.37% of its revenue coming from thermal management materials and devices [1] Shareholder Information - Southern Fund's Southern CSI 1000 ETF (512100) entered the top ten circulating shareholders of Suzhou Tianmai in the second quarter, holding 216,500 shares, which is 0.83% of the circulating shares [2] - The ETF has a total scale of 64.953 billion CNY and has achieved a year-to-date return of 22.89%, ranking 2070 out of 4218 in its category [2] Fund Management - The fund manager of Southern CSI 1000 ETF is Cui Lei, who has been in the position for 6 years and 350 days, with a total asset scale of 94.976 billion CNY [3] - During Cui Lei's tenure, the best fund return was 167.96%, while the worst was -16.06% [3]

证券日报网讯 10月20日晚间，苏州天脉发布公告称，近日，公司竞拍取得了苏州市自然资源和规划局 挂牌出让的宗地编号为"苏吴国土2025-WG-14号"的国有建设用地使用权，并与苏州市自然资源和规划 局签订《国有建设用地使用权出让合同》。 （文章来源：证券日报） ...

Group 1 - Yonghe Co., Ltd. reported a net profit of 469 million yuan for the first three quarters, a year-on-year increase of 220.39% [1] - Jinli Permanent Magnet achieved a net profit of 515 million yuan, reflecting a year-on-year growth of 161.81% [1][2] - Sanhe Pharmaceutical Auxiliary's net profit increased by 8.28% year-on-year, reaching 133 million yuan [2] Group 2 - Jiahuan Technology experienced a net profit decline of 26.53%, totaling 55.35 million yuan [3] - Wuchan Huaneng reported a net profit decrease of 15.10%, amounting to 453 million yuan [3] - Chuan Investment Energy's net profit fell by 4.54%, totaling 4.22 billion yuan [4][5] Group 3 - Dayang Bio's net profit grew by 56.12%, reaching 80 million yuan [5] - Weili Medical reported a net profit increase of 14.94%, totaling 192 million yuan [6] - People's Tongtai's net profit decreased by 45.69%, amounting to 112 million yuan [7] Group 4 - Jiuhuan Bio received a medical device registration certificate for its NT-proBNP test kit [8] - Jincheng Pharmaceutical's subsidiary obtained a drug registration certificate for a specific injection [9] - Guangdian Yuntong's subsidiary acquired a money service operator license in Hong Kong [10] Group 5 - Dash Intelligent won a bid for a project worth 96 million yuan related to the Shijiazhuang subway [10] - Alloy Investment's net profit increased by 124.87%, reaching 7.26 million yuan [11] - Kaile Co., Ltd. reported a net profit growth of 159.14%, totaling 21.63 million yuan [12] Group 6 - Chuanjinno's net profit surged by 175.61%, reaching 304 million yuan [14] - Rijiu Optoelectronics reported a net profit increase of 36.54%, totaling 76.91 million yuan [15] - Dazhu CNC's net profit grew by 142.19%, amounting to 492 million yuan [15] Group 7 - Nairui Radar expects a net profit increase of 181% for the first three quarters [17] - Suzhou Tianmai successfully acquired land use rights for a new manufacturing project [19] - Aokai Pharmaceutical announced clinical research data for its innovative drug at a major conference [21][22] Group 8 - Jilin Aodong's subsidiary passed the consistency evaluation for a specific injection [24] - Qinxin Environment announced the resignation of a board member [25] - *ST Baoying is planning a change in control, leading to a stock suspension [26] Group 9 - Jianlang Hardware's director plans to reduce holdings by up to 500,000 shares [27] - Taihe Technology's director intends to reduce holdings by up to 606,000 shares [29] - Zhongyuan Securities announced a cash dividend of 0.008 yuan per share [31] Group 10 - Beijing-Shanghai High-Speed Railway plans to distribute a cash dividend of 0.0385 yuan per share [32] - Zhuhai Guanyu expects a net profit increase of 36.88%-55.54% for the first three quarters [34] - Shenglong Co., Ltd. reported a net loss of 72.95 million yuan for the first three quarters [36] Group 11 - Shuangyuan Technology plans to distribute a cash dividend of 0.125 yuan per share [38] - Shaanxi Guotou A reported a net profit increase of 6.6%, totaling 996 million yuan [40] - Sunshine Nuohua intends to invest 15 million yuan in a biotech company [41] Group 12 - Yangjie Technology's net profit increased by 45.51%, reaching 974 million yuan [42] - Xingwang Yuda reported a net profit growth of 260%, totaling 38.37 million yuan [43] - Tongyou Technology turned a profit with a net profit of 9.29 million yuan [44]